Since there are limitations in both sensitivity and specificity when using single protein as a biomarker, the combination of CD147, AFP, and potentially other clinical indices/biomarkers may improve diagnostic efficiency and stage determination in HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.